Stratec (SBSD) Stock Overview
Provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
SBSD Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Stratec SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €30.68 |
| 52 Week High | €30.68 |
| 52 Week Low | €27.48 |
| Beta | 0.72 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -7.47% |
| 3 Year Change | -64.46% |
| 5 Year Change | -74.65% |
| Change since IPO | -42.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| SBSD | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | 3.2% | -1.0% |
| 1Y | -7.5% | -9.1% | 15.2% |
Return vs Industry: SBSD underperformed the UK Medical Equipment industry which returned 18.3% over the past year.
Return vs Market: SBSD underperformed the UK Market which returned 21.2% over the past year.
Price Volatility
| SBSD volatility | |
|---|---|
| SBSD Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in GB Market | 11.7% |
| 10% least volatile stocks in GB Market | 3.1% |
Stable Share Price: SBSD's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine SBSD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 1,420 | Marcus Wolfinger | www.stratec.com |
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software.
Stratec SE Fundamentals Summary
| SBSD fundamental statistics | |
|---|---|
| Market cap | €266.82m |
| Earnings (TTM) | €15.36m |
| Revenue (TTM) | €260.25m |
Is SBSD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SBSD income statement (TTM) | |
|---|---|
| Revenue | €260.25m |
| Cost of Revenue | €185.90m |
| Gross Profit | €74.36m |
| Other Expenses | €59.00m |
| Earnings | €15.36m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.26 |
| Gross Margin | 28.57% |
| Net Profit Margin | 5.90% |
| Debt/Equity Ratio | 55.1% |
How did SBSD perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/20 16:28 |
| End of Day Share Price | 2025/09/22 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Stratec SE is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Heider | Berenberg |
| Jan Koch | Deutsche Bank |
| Yi-Dan Wang | Deutsche Bank |